Read + Share
Amedeo Smart
Independent Medical Education
Horby P, Staplin N, Haynes R, Landray M, et al. Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply. Lancet 2021;398:300.PMID: 34303433
Email
LinkedIn
Facebook
Twitter
Privacy Policy